Ditropan and Requip drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ditropan and Requip. Common interactions include constipation among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people who take Ditropan and Requip have. It is created by eHealthMe based on reports of 145 people who take Ditropan and Requip from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
145 people who take Ditropan and Requip together, and have interactions are studied.
What is Ditropan?
Ditropan has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 11,272 Ditropan users for its effectiveness, alternative drugs and more.
What is Requip?
Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,097 Requip users for its effectiveness, alternative drugs and more.
Number of Ditropan and Requip reports submitted per year:
Ditropan and Requip drug interactions by gender *:
Ditropan and Requip drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Ditropan and Requip?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Ditropan and Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Ditropan side effects:
- Weakness: 797 reports
- Urinary tract infection: 792 reports
- Fatigue (feeling of tiredness): 753 reports
- Drug ineffective: 639 reports
- Pain: 617 reports
- Headache (pain in head): 616 reports
- Dizziness: 574 reports
Browse all side effects of Ditropan:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Requip side effects:
- Drug ineffective: 1,870 reports
- Fatigue (feeling of tiredness): 1,331 reports
- Drowsiness: 1,164 reports
- Dizziness: 1,134 reports
- Pain: 1,043 reports
Browse all side effects of Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Ditropan interactions:
- Ditropan and Aspirin: 1,204 reports
- Ditropan and Baclofen: 1,110 reports
- Ditropan and Synthroid: 1,107 reports
- Ditropan and Lasix: 963 reports
- Ditropan and Neurontin: 933 reports
- Ditropan and Lipitor: 920 reports
- Ditropan and Prilosec: 918 reports
- Ditropan and Avonex: 741 reports
- Ditropan and Nexium: 738 reports
- Ditropan and Tylenol: 729 reports
Browse all interactions between Ditropan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Requip interactions:
- Requip and Aspirin: 2,449 reports
- Requip and Sinemet: 1,967 reports
- Requip and Gabapentin: 1,668 reports
- Requip and Lasix: 1,564 reports
- Requip and Lyrica: 1,561 reports
- Requip and Lisinopril: 1,558 reports
- Requip and Synthroid: 1,505 reports
- Requip and Cymbalta: 1,494 reports
- Requip and Lipitor: 1,409 reports
- Requip and Neurontin: 1,258 reports
Browse all interactions between Requip and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on oxybutynin chloride and ropinirole hydrochloride (the active ingredients of Ditropan and Requip, respectively), and Ditropan and Requip (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Ditropan and Requip.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Carbamazepine and Metastasis - now
- Amoxil and Naprosyn drug interaction - 2 seconds ago
- Vascepa and Inflammation - 13 seconds ago
- Vesicare and Cystitis Interstitial - 19 seconds ago
- Effexor Xr and Seronegative Arthritis - 24 seconds ago
- Genotropin and Primary Hypothyroidism - 25 seconds ago
- Innohep and Urination - Excessive Volume - 28 seconds ago
- Meclizine and Skin Reaction - 44 seconds ago
- Crohn'S Disease and Gastrointestinal Pain - 45 seconds ago
- Prograf and Spinal Osteoarthritis - 49 seconds ago